These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 30822)
1. Post-mortem stability of monoamine oxidase in rat tissues. Parkinson D; Callingham BA J Pharm Pharmacol; 1978 Oct; 30(10):648-51. PubMed ID: 30822 [No Abstract] [Full Text] [Related]
2. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat. Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813 [TBL] [Abstract][Full Text] [Related]
3. Substrate selectivity of type A and type B monoamine oxidase in rat brain. Kinemuchi H; Wakui Y; Kamijo K J Neurochem; 1980 Jul; 35(1):109-15. PubMed ID: 6778959 [No Abstract] [Full Text] [Related]
4. Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase. Fowler CJ; Strolin Benedetti M J Neurochem; 1983 Feb; 40(2):510-3. PubMed ID: 6822834 [TBL] [Abstract][Full Text] [Related]
5. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria. Egashira T; Ekstedt B; Oreland L Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579 [No Abstract] [Full Text] [Related]
6. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation. Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471 [No Abstract] [Full Text] [Related]
7. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145. Azam M; Jain S; Baquer NZ Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104 [TBL] [Abstract][Full Text] [Related]
8. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction. Shekhar C; Mayanil K; Baquer NZ Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972 [TBL] [Abstract][Full Text] [Related]
9. Proceedings: Monoamine oxidase activity in distinct populations of rat brain mitochondria. Bourne R; Lai JC; Owen F; Crow TJ Br J Pharmacol; 1975 Oct; 55(2):298P. PubMed ID: 1201425 [No Abstract] [Full Text] [Related]
10. Rat and human cardiac monoamine oxidase: a comparison with other tissues. Dial EJ; Clarke DE Eur J Pharmacol; 1979 Oct; 58(3):313-9. PubMed ID: 510362 [TBL] [Abstract][Full Text] [Related]
11. Substrate and inhibitor selectivity of human heart monoamine oxidase. Parkinson D; Callingham BA Biochem Pharmacol; 1979 May; 28(10):1639-43. PubMed ID: 38793 [No Abstract] [Full Text] [Related]
13. The heterogeneity of monoamine oxidase in distinct populations of rat brain mitochondria. Owen F; Bourne R Biochem Pharmacol; 1977 Feb; 26(4):289-92. PubMed ID: 849318 [No Abstract] [Full Text] [Related]
14. Monoamine oxidase in four rat and human tissues. Haenick D; Boehme DH; Vogel WH Biochem Med; 1981 Dec; 26(3):451-4. PubMed ID: 7332547 [No Abstract] [Full Text] [Related]
15. Phenylethanolamine is a specific substrate for type B monoamine oxidase. Edwards DJ Life Sci; 1978 Sep; 23(11):1201-7. PubMed ID: 713694 [No Abstract] [Full Text] [Related]
16. The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers. Fowler CJ; Callingham BA Mol Pharmacol; 1979 Sep; 16(2):546-55. PubMed ID: 514258 [No Abstract] [Full Text] [Related]
17. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity. Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699 [TBL] [Abstract][Full Text] [Related]
18. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone. Fowler CJ; Benedetti MS J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646 [TBL] [Abstract][Full Text] [Related]